SCHEMBL3099765

SCHEMBL3099765

CN(C(=O)O)[C@H](C(=O)N[C@@H](Cc1ccccc1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)OCC1c2ccccc2-c2ccccc21)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ SLC22A2 O15244 1/20 0.40
▸ SLC22A1 O15245 1/20 0.40
▸ ABCC3 O15438 1/20 0.40
▸ ABCC4 O15439 1/20 0.40
▸ MLNR O43193 1/20 0.40
▸ NR1I2 O75469 1/20 0.40
▸ SLCO2B1 O94956 1/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PGR P06401 1/20 0.40
▸ ABCB1 P08183 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3801376 0.86 CYP3A4 (0.50) CA2CYP3A4CASP3KLK5L3MBTL1
SCHEMBL2437040 0.85 CA2 (0.41) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL8669416 0.84 KLK5 (0.52) CASP3KLK5PSEN1PSEN2APH1B
SCHEMBL2440633 0.80 ATM (0.50) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL2440631 0.80 ATM (0.50) KLK5PSEN1PSEN2APH1BNCSTN
SCHEMBL3803057 0.79 CASP3 (0.42) CA2CYP3A4MEN1SLC22A2SLC22A1
SCHEMBL8670056 0.77 KMT2A (0.47) KMT2ACASP3MDM4TP53
SCHEMBL2438166 0.77 CA2 (0.42) CA2CYP3A4MAPK1OPRM1OPRD1
SCHEMBL8889416 0.77 KMT2A (0.47) KMT2ACASP3MDM4TP53
SCHEMBL894104 0.76 BCHE (0.44) CA2KLK5PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834043-B2 Prevent reproduct of aids virus ABBOTT LABORATORIES (US) 2010-11-16 — — US disclosed
US-20100249181-A1 HIV Protease Inhibiting Compounds ABBOTT LABORATORIES (US) 2010-09-30 — — US disclosed
US-20050148623-A1 Prevent reproduct of aids virus ABBVIE INC. 2005-07-07 — — US disclosed
US-20050131017-A1 HIV protease inhibiting compounds ABBOTT LABORATORIES 2005-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148623-A1 Prevent reproduct of aids virus SERPINB1, PRSS1, SERPINA3 CA2 4400/4885CYP3A4 481/4885MEN1 2754/4885
US-20050131017-A1 HIV protease inhibiting compounds SERPINB1, HPN, DNPEP CA2 3870/4885CYP3A4 764/4885MEN1 4515/4885
US-20100249181-A1 HIV Protease Inhibiting Compounds SERPINB1, HPN, DNPEP CA2 3870/4885CYP3A4 764/4885MEN1 4515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback